Improving the expression of smell receptors for studying how they interact with odors
Enhancing olfactory receptor expression for biochemical studies of odorant-receptor interactions
This study is exploring new ways to boost the activity of smell-related receptors in the body, which could help us understand their role in health and diseases like cancer, and it's designed for anyone interested in how our sense of smell affects our overall well-being.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11041035 on NIH RePORTER |
What this research studies
This research focuses on enhancing the expression of olfactory receptors (ORs), which play a crucial role in our sense of smell and are also involved in various physiological processes in the body, including cancer. The researchers aim to overcome challenges related to the low expression of these receptors in laboratory settings by engineering mutant ORs, allowing for better biochemical studies. By using a combination of computational methods and experimental testing, they hope to discover new ways to activate and inhibit these receptors effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals with conditions related to olfactory receptor dysfunction or those affected by cancers where these receptors are implicated.
Not a fit: Patients with conditions unrelated to olfactory receptors or those not affected by the physiological roles of these receptors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new insights into how olfactory receptors function, potentially impacting treatments for conditions related to these receptors, including certain cancers.
How similar studies have performed: While the exploration of olfactory receptors is a relatively novel area, previous studies have shown promise in enhancing receptor expression and understanding their functions.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Matsunami, Hiroaki — Duke University
- Study coordinator: Matsunami, Hiroaki
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.